This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Secrier, M. et al. Nat. Genet. 48, 1131–1141 (2016).
Frankell, A. M. et al. Nat. Genet. 51, 506–516 (2019).
Li, X. et al. Nat. Commun. 9, 2983 (2018).
Mourikis, T. P. et al. Nat. Commun. 10, 3101 (2019).
Rahman, S. A. et al. Br. J. Surg. 107, 1042–1052 (2020).
Rogerson, C. et al. eLife 9, e57189 (2020).
The ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium. Nature 578, 82–93 (2020).
Nowicki-Osuch, K. et al. Science 373, 760–767 (2021).
Ococks, E. et al. Ann. Oncol. 32, 522–532 (2021).
Luebeck, J. et al. Nature 616, 798–805 (2023).
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Competing interests
Grant funding for OCCAMS infrastructure was provided by Cancer Research UK. Project specific funding for commercial assay technologies applied to OCCAMS samples was provided by Roche and Natera. R.F. is a shareholder in Cyted Ltd, an early diagnosis company.
Rights and permissions
About this article
Cite this article
Peters, C.J., Ang, Y., Ciccarelli, F.D. et al. A decade of the Oesophageal Cancer Clinical and Molecular Stratification Consortium. Nat Med 30, 14–16 (2024). https://doi.org/10.1038/s41591-023-02676-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-023-02676-y